Luc Bonnefoy's most recent trade in Bausch + Lomb Corp was a trade of 9,221 Common Shares, No Par Value done at an average price of $18.3 . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bausch + Lomb Corp | Luc Bonnefoy | President, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.30 per share. | 26 Feb 2026 | 9,221 | 100,001 | - | 18.3 | 168,744 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.49 per share. | 26 Feb 2026 | 4,404 | 113,533 | - | 18.5 | 81,430 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.30 per share. | 26 Feb 2026 | 4,311 | 109,222 | - | 18.3 | 78,891 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 30,373 | 117,937 | - | 0 | Common Shares, No Par Value | |
| Bausch + Lomb Corp | Luc Bonnefoy | President, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 10,202 | 87,564 | - | 0 | Common Shares, No Par Value | |
| Bausch + Lomb Corp | Luc Bonnefoy | President, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 6,146 | 77,362 | - | 0 | Common Shares, No Par Value | |
| Bausch + Lomb Corp | Luc Bonnefoy | President, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.32 per share. | 25 Jul 2025 | 2,167 | 71,216 | - | 14.3 | 31,031 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.33 per share. | 13 Jun 2025 | 968 | 73,383 | - | 12.3 | 11,935 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President,Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.00 per share. | 28 Feb 2025 | 3,029 | 74,351 | - | 16 | 48,464 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President,Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.00 per share. | 28 Feb 2025 | 1,110 | 77,380 | - | 16 | 17,760 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President,Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 55,793 | 55,793 | - | - | Non-Qualified Stock Options (right to purchase) | |
| Bausch + Lomb Corp | Luc Bonnefoy | President,Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 23,423 | 78,490 | - | 0 | Common Shares, No Par Value | |
| Bausch + Lomb Corp | Luc Bonnefoy | President,Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.53 per share. | 25 Jul 2024 | 2,144 | 55,067 | - | 15.5 | 33,296 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President,Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.09 per share. | 14 Jun 2024 | 958 | 57,211 | - | 15.1 | 14,456 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President,Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.47 per share. | 01 Mar 2024 | 1,098 | 58,169 | - | 16.5 | 18,084 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Luc Bonnefoy | President,Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 50,813 | 50,813 | - | - | Non-Qualified Stock Options (right to purchase) | |
| Bausch + Lomb Corp | Luc Bonnefoy | President,Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 16,778 | 59,267 | - | 0 | Common Shares, No Par Value |